138 related articles for article (PubMed ID: 23033255)
1. Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Ren S; Zeng J; Mei Y; Zhang JZ; Yan SF; Fei J; Chen L
Drug Metab Dispos; 2013 Jan; 41(1):60-71. PubMed ID: 23033255
[TBL] [Abstract][Full Text] [Related]
2. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Lee CA; Jones JP; Katayama J; Kaspera R; Jiang Y; Freiwald S; Smith E; Walker GS; Totah RA
Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
[TBL] [Abstract][Full Text] [Related]
3. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
Lee E; Wu Z; Shon JC; Liu KH
Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel substrates for human cytochrome P450 2J2.
Lee CA; Neul D; Clouser-Roche A; Dalvie D; Wester MR; Jiang Y; Jones JP; Freiwald S; Zientek M; Totah RA
Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
Xu M; Ju W; Hao H; Wang G; Li P
Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.
Ikemura N; Yamaori S; Kobayashi C; Kamijo S; Murayama N; Yamazaki H; Ohmori S
Chem Biol Interact; 2019 Jun; 306():1-9. PubMed ID: 30965050
[TBL] [Abstract][Full Text] [Related]
7. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
Lu J; Liu D; Zhou X; Chen A; Jiang Z; Ye X; Liu M; Wang X
Phytomedicine; 2018 Jan; 39():137-145. PubMed ID: 29433675
[TBL] [Abstract][Full Text] [Related]
8. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
Phuc NM; Wu Z; O Y; Lee JH; Oh S; Song GY; Liu KH
Drug Metab Dispos; 2017 Jul; 45(7):765-769. PubMed ID: 28461575
[TBL] [Abstract][Full Text] [Related]
9. Effects of cytochrome P450 inhibitors on peroxidase activity.
Martinkova M; Kubickova B; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():33-40. PubMed ID: 23353841
[TBL] [Abstract][Full Text] [Related]
10. Characterization of intestinal and hepatic P450 enzymes in cynomolgus monkeys with typical substrates and inhibitors for human P450 enzymes.
Yoda N; Emoto C; Date S; Kondo S; Miyake M; Nakazato S; Umehara K; Kashiyama E
Xenobiotica; 2012 Aug; 42(8):719-30. PubMed ID: 22324396
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole.
Matsumoto S; Hirama T; Matsubara T; Nagata K; Yamazoe Y
Drug Metab Dispos; 2002 Nov; 30(11):1240-5. PubMed ID: 12386130
[TBL] [Abstract][Full Text] [Related]
12. Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2.
Lafite P; Dijols S; Zeldin DC; Dansette PM; Mansuy D
Arch Biochem Biophys; 2007 Aug; 464(2):155-68. PubMed ID: 17470359
[TBL] [Abstract][Full Text] [Related]
13. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
[TBL] [Abstract][Full Text] [Related]
14. Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites.
Karkhanis A; Lam HY; Venkatesan G; Koh SK; Chai CL; Zhou L; Hong Y; Kojodjojo P; Chan EC
Biochem Pharmacol; 2016 May; 107():67-80. PubMed ID: 26972388
[TBL] [Abstract][Full Text] [Related]
15. Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes.
Lee E; Kim JH; Shon JC; Wu Z; Kim HJ; Gim M; Lee T; Liu KH
Drug Metab Pharmacokinet; 2018 Jun; 33(3):159-163. PubMed ID: 29759885
[TBL] [Abstract][Full Text] [Related]
16. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.
Lee KS; Kim SK
J Appl Toxicol; 2013 Feb; 33(2):100-8. PubMed ID: 21915887
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes.
Kim KA; Lee JS; Park HJ; Kim JW; Kim CJ; Shim IS; Kim NJ; Han SM; Lim S
Life Sci; 2004 Apr; 74(22):2769-79. PubMed ID: 15043991
[TBL] [Abstract][Full Text] [Related]
18. Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant.
Zhao T; Chen Y; Wang D; Wang L; Dong P; Zhao S; Wang C; Meng Q; Sun H; Liu K; Wu J
Cardiovasc Drugs Ther; 2022 Feb; 36(1):121-129. PubMed ID: 33411110
[TBL] [Abstract][Full Text] [Related]
19. Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors.
Leow JWH; Verma RK; Lim ABH; Fan H; Chan ECY
Eur J Pharm Sci; 2021 Sep; 164():105889. PubMed ID: 34044117
[TBL] [Abstract][Full Text] [Related]
20. Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes.
Evangelista EA; Kaspera R; Mokadam NA; Jones JP; Totah RA
Drug Metab Dispos; 2013 Dec; 41(12):2087-94. PubMed ID: 24021950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
